Home › Funds › Balyasny Asset Management › BMEA
Balyasny Asset Management position in BMEA
BIOMEA FUSION INC · Health Care
Latest position (Q3 2024)40.48K sh
Reported value held$408.82K
Portfolio Weight0.00%
First reportedQ4 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 10.42K | $87.85K | New |
| Q1 2023 | 7.70K | $238.62K | Reduce |
| Q4 2023 | 22.43K | $325.65K | New |
| Q1 2024 | 27.12K | $405.50K | Add |
| Q2 2024 | 15.70K | $70.65K | Reduce |
| Q3 2024 | 40.48K | $408.82K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BMEA
- Fidelity Management & Research (FMR) 8.81M sh · $12.96M · Q2 2026
- Vanguard Group 2.97M sh · $3.68M · Q4 2025
- Marshall Wace 2.05M sh · $3.01M · Q2 2026
- Renaissance Technologies 1.46M sh · $2.14M · Q2 2026
- BlackRock Inc 715.45K sh · $1.05M · Q2 2026
- Geode Capital Management 708.85K sh · $1.04M · Q2 2026
- UBS Group AG 444.73K sh · $653.75K · Q2 2026
- Two Sigma Investments 384.46K sh · $565.15K · Q2 2026
- Morgan Stanley 367.02K sh · $539.52K · Q2 2026
- Citadel Advisors 236.42K sh · $347.53K · Q2 2026
- Northern Trust Corp 128.53K sh · $188.93K · Q2 2026
- Goldman Sachs Group 93.76K sh · $137.82K · Q2 2026